Literature DB >> 23769810

The additional value of endometrial sampling in the early detection of endometrial cancer in women with Lynch syndrome.

J M Helder-Woolderink1, G H De Bock, R H Sijmons, H Hollema, M J E Mourits.   

Abstract

OBJECTIVE: Based on previous studies, standard gynecological screening consisting of annual transvaginal ultrasonography (TVU) was added with endometrial sampling in women with Lynch syndrome (LS). The aim of this study was to evaluate the additional value of endometrial sampling in detecting (pre)malignancies of the endometrial tissue in women with LS or first-degree relatives.
METHODS: All women above 30 years of age with LS or first-degree relatives at 50% risk of LS are offered annual gynecological screening in our family cancer clinic. Endometrial screening results from January 2003-December 2007 (period I: standard screening by transvaginal sonography and serum CA125) were compared with screening results from January 2008-June 2012 (period II: standard screening added with endometrial sampling).
RESULTS: Seventy five women (300 patient years) were screened annually. There were 266 screening visits, 117 in period I and 149 in period II. In period I, four premalignant endometrial lesions were detected and one endometrial carcinoma (FIGO stage IB). In period II, two premalignancies were found. None of the lesions would have been missed without standard endometrial sampling. No interval endometrial cancers were detected in this study.
CONCLUSION: In this study, annual endometrial screening seems an effective screening tool in the detection of premalignancies and early endometrial cancer in women with LS. Adding standard endometrial sampling to annual TVU has no additional value in the early detection of (pre)malignant endometrial lesions in women with LS in this study.
Copyright © 2013. Published by Elsevier Inc.

Entities:  

Keywords:  Endometrial cancer; Gynecological screening; HNPCC; Lynch syndrome; Microcurettage; Premalignancy

Mesh:

Year:  2013        PMID: 23769810     DOI: 10.1016/j.ygyno.2013.05.032

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Management of ovarian and endometrial cancers in women belonging to HNPCC carrier families: review of the literature and results of cancer risk assessment in Polish HNPCC families.

Authors:  Tadeusz Dębniak; Tomasz Gromowski; Rodney J Scott; Jacek Gronwald; Tomasz Huzarski; Tomasz Byrski; Grzegorz Kurzawski; Dagmara Dymerska; Bohdan Górski; Katarzyna Paszkowska-Szczur; Cezary Cybulski; Pablo Serrano-Fernandez; Jan Lubiński
Journal:  Hered Cancer Clin Pract       Date:  2015-01-16       Impact factor: 2.857

2.  Pain evaluation during gynaecological surveillance in women with Lynch syndrome.

Authors:  Jorien Helder-Woolderink; Geertruida de Bock; Harry Hollema; Magda van Oven; Marian Mourits
Journal:  Fam Cancer       Date:  2017-04       Impact factor: 2.375

3.  Screening and risk reducing surgery for endometrial or ovarian cancers in Lynch syndrome: a systematic review.

Authors:  Natalie Lim; Martha Hickey; Graeme P Young; Finlay A Macrae; Christabel Kelly
Journal:  Int J Gynecol Cancer       Date:  2022-05-03       Impact factor: 4.661

4.  Potential of blood-based biomarker approaches in endometrium and breast cancer: a case-control comparison study.

Authors:  Anne Schuhn; Tania Witte Tobar; Aoife Ward Gahlawat; Jana Hauke; Lukas Baumann; Jürgen G Okun; Juliane Nees
Journal:  Arch Gynecol Obstet       Date:  2022-03-13       Impact factor: 2.493

5.  Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndrome.

Authors:  Melissa K Frey; Gizelka David-West; Khushbakhat R Mittal; Franco M Muggia; Bhavana Pothuri
Journal:  Ecancermedicalscience       Date:  2016-01-18

6.  Interdisciplinary Diagnosis, Therapy and Follow-up of Patients with Endometrial Cancer. Guideline (S3-Level, AWMF Registry Nummer 032/034-OL, April 2018) - Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer.

Authors:  Günter Emons; Eric Steiner; Dirk Vordermark; Christoph Uleer; Nina Bock; Kerstin Paradies; Olaf Ortmann; Stefan Aretz; Peter Mallmann; Christian Kurzeder; Volker Hagen; Birgitt van Oorschot; Stefan Höcht; Petra Feyer; Gerlinde Egerer; Michael Friedrich; Wolfgang Cremer; Franz-Josef Prott; Lars-Christian Horn; Heinrich Prömpeler; Jan Langrehr; Steffen Leinung; Matthias W Beckmann; Rainer Kimmig; Anne Letsch; Michael Reinhardt; Bernd Alt-Epping; Ludwig Kiesel; Jan Menke; Marion Gebhardt; Verena Steinke-Lange; Nils Rahner; Werner Lichtenegger; Alain Zeimet; Volker Hanf; Joachim Weis; Michael Mueller; Ulla Henscher; Rita K Schmutzler; Alfons Meindl; Felix Hilpert; Joan Elisabeth Panke; Vratislav Strnad; Christiane Niehues; Timm Dauelsberg; Peter Niehoff; Doris Mayr; Dieter Grab; Michael Kreißl; Ralf Witteler; Annemarie Schorsch; Alexander Mustea; Edgar Petru; Jutta Hübner; Anne Derke Rose; Edward Wight; Reina Tholen; Gerd J Bauerschmitz; Markus Fleisch; Ingolf Juhasz-Boess; Lax Sigurd; Ingo Runnebaum; Clemens Tempfer; Monika J Nothacker; Susanne Blödt; Markus Follmann; Thomas Langer; Heike Raatz; Simone Wesselmann; Saskia Erdogan
Journal:  Geburtshilfe Frauenheilkd       Date:  2018-10-19       Impact factor: 2.915

7.  Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.

Authors:  Nuria Dueñas; Matilde Navarro; Àlex Teulé; Ares Solanes; Mònica Salinas; Sílvia Iglesias; Elisabet Munté; Jordi Ponce; Jordi Guardiola; Esther Kreisler; Elvira Carballas; Marta Cuadrado; Xavier Matias-Guiu; Napoleón de la Ossa; Joan Lop; Conxi Lázaro; Gabriel Capellá; Marta Pineda; Joan Brunet
Journal:  Cancers (Basel)       Date:  2020-11-18       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.